SCHEMBL4783918

SCHEMBL4783918

O=C1C=C(c2cccs2)C(=O)c2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.55
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
CDC25B P30305 3/20 0.44
ALDH1A1 P00352 3/20 0.44
HPGD P15428 2/20 0.44
KMT2A Q03164 2/20 0.44
IDO1 P14902 2/20 0.44
CDC25A P30304 2/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
MAPK1 P28482 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MEN1 O00255 1/20 0.44
PLIN1 O60240 1/20 0.44
NR1I2 O75469 1/20 0.44
USP2 O75604 1/20 0.44
GSR P00390 1/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30821340 0.89 BACE1 (0.44) BACE1ADORA2AADORA1CDC25BALDH1A1
SCHEMBL142991 0.86 PTPN1 (0.55) ADORA2AADORA1CDC25BALDH1A1HPGD
SCHEMBL28738042 0.82 PTAFR (0.41) BACE1ADORA2AADORA1CDC25BALDH1A1
SCHEMBL6555840 0.78 BACE1 (0.75) BACE1CDC25BALDH1A1HPGDKMT2A
SCHEMBL29673492 0.71 BACE1 (1.00) BACE1CDC25BALDH1A1HPGDKMT2A
SCHEMBL8596446 0.71 PTPN1 (0.64) BACE1CDC25BALDH1A1HPGDKMT2A
SCHEMBL5485068 0.71 BACE1 (1.00) BACE1CDC25BALDH1A1HPGDKMT2A
SCHEMBL17717551 0.69 ALDH1A1 (0.38) ALDH1A1HPGDKMT2ALMNAMAPT
SCHEMBL3951353 0.69 ADORA2A (0.53) ADORA2AADORA1CDC25BALDH1A1HPGD
SCHEMBL9286666 0.69 BACE1 (0.60) BACE1CDC25BALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008136642-A1 NAPHTHOQUINONE-BASED PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF DISEASES INVOLVING OBESITY, DIABETES, METABOLIC SYNDROME, NEURO-DEGENERATIVE DISEASES AND MITOCHONDRIA DYSFUNCTION DISEASES MAZENCE INC. (KR) 2008-11-13 WO disclosed
WO-2008066300-A1 NAPHTHOQUINONE-BASED PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF DISEASES INVOLVING OBESITY, DIABETES, METABOLIC SYNDROME, NEURO-DEGENERATIVE DISEASES AND MITOCHONDRIA DYSFUNCTION DISEASES MAZENCE INC. (KR) 2008-06-05 WO disclosed
EP-0560683-A1 Hair coloring compositions with monoindolyl-1,4-naphthoquinones or their leuko derivatives, new monoindolyl-1,4-naphthoquinones and their leukoderivatives L'OREAL (FR) 1993-09-15 EP disclosed
EP-0560684-A1 1,4-naphthoquinone or 1,4-naphthalenediol compounds di- or tri-indolyl substituted, processes for their preparation and their use for dyeing keratinous material L'OREAL (FR) 1993-09-15 EP disclosed